SFX by Ex Libris Inc.

Title:	Biological effects of group IIA secreted phosholipase A2
Source:	Febs Letters [0014-5793] Fuentes, Lucı́a yr:2002

Basic

Full text

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Eswarakumar, V P P. "Cellular signaling by fibroblast growth factor receptors." Cytokine & growth factor reviews 16.2: 139-149.
description	2.	Touqui, L. "Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases." Current molecular medicine 1.6 (2002): 739-54.
description	3.	Ibrahimi, Omar A A. "Structural basis for fibroblast growth factor receptor activation." Cytokine & growth factor reviews 16.2 (2005): 107-37.
description	4.	Plotnikov, A N N. "Structural basis for FGF receptor dimerization and activation." Cell 98.5 (1999): 641-50.
description	5.	Knowles, Margaret A A. "Cell responses to FGFR3 signalling: growth, differentiation and apoptosis." Experimental cell research 304.2 (2005): 417-31.
description	6.	Basilico, C. "Mechanisms underlying differential responses to FGF signaling." Cytokine & growth factor reviews 16.2 (2005): 233-247.
description	7.	Peuravuori, H. "Group IIA phospholipase A2 content of tears in patients with atopic blepharoconjunctivitis." Graefe's archive for clinical and experimental ophthalmology 242.12 (2004): 986-989.
description	8.	Aoki, J. "Mechanisms of lysophosphatidic acid production." Seminars in cell & developmental biology 15.5 (2004): 477-89.
description	9.	Song, C. "Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment." The journal of neuroscience 29.1 (2009): 14-22.
description	10.	Kononen, O P P. "Tissue microarrays for high-throughput molecular profiling of tumor specimens." Nature medicine 4.7 (1998): 844-7.
description	11.	Nocito, A. "Tissue microarrays (TMAs) for high-throughput molecular pathology research." International journal of cancer 94.1 (2001): 1-5.
description	12.	Degnin, C. "FGFs in Endochondral Skeletal Development." Journal of cellular biochemistry 110.5 (2010): 1046-1057.
description	13.	Hart, K C. "Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation." Molecular biology of the cell 12.4 (2001): 931-42.
description	14.	Horton, William A A. "Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism." Reviews in endocrine & metabolic disorders 3.4 (2003): 381-5.
description	15.	Boilly, B. "FGF signals for cell proliferation and migration through different pathways." Cytokine & growth factor reviews 11.4 (2000): 295-302.
description	16.	Ornitz, David M M. "FGF signaling in the developing endochondral skeleton." Cytokine & growth factor reviews 16.2 (2005): 205-213.
description	17.	Aleck, K. "Craniosynostosis syndromes in the genomic era." Seminars in pediatric neurology 11.4 (2005): 256-61.
description	18.	Höglund, M. "Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q." Oncogene 25.18 (2006): 2685-2696.
description	19.	Wilkie, S. "Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis." American Journal of Human Genetics 70.2 (2002): 472-86.
description	20.	Tang, M. "Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors." Science 276.5314 (1997): 955-60.